Despite growing interest in metabolically healthy obesity (MHO) as a distinct phenotype, our results suggest that the follistatin levels do not differ significantly between metabolically healthy and unhealthy individuals. Here, FST is linked to obesity due to melanocortin 4 receptor deficiency.